BIOCARDIA INC Revenue, Profits - BCDA Annual Income Statement

Add to My Stocks
$1.7 $0.28 (19.72%) BCDA stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the BIOCARDIA INC stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for BCDA which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with BIOCARDIA INC assets and BIOCARDIA INC free cash flow, BIOCARDIA INC profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-12.3M and the 2017 revenue is $-.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
BIOCARDIA INC Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Research & Development Expense5.79M3.33M------1M1.33M
Selling General & Admin Expense6.39M4.1M------5.58M5.37M
Income Before Depreciation Depletion Amortization-12.4M-7.6M----0.33M-0.61M-0.58M-5.1M-5.63M
Depreciation Depletion Amortization----------
Non Operating Income--2.7M-----0.01M---0.16M
Interest Expense----------
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-12.3M-10.31M----0.33M-0.63M-0.55M-5.07M-5.8M
Extraordinary Items & Discontinued Operations------10.29M-10.95M--
BIOCARDIA INC Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS38.16M-230.29M230.29M230.29M230.29M----
Average Shares used to compute Basic EPS38.16M-230.29M230.29M230.29M230.29M----
Income Before Nonrecurring Items-12.31M-----0.33M----
Income from Nonrecurring Items----------
BIOCARDIA INC Earnings Per Share Basic Net
BIOCARDIA INC Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.32-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our CONMED financial analysis

Before investing one should read a report on BIOCARDIA INC stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that BCDA stock has a topline or revenue of $- for 2017 as per this BIOCARDIA INC revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-12.3M for BCDA stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The BCDA financials along with BIOCARDIA INC historical stock prices provide a lot of details about the firm.

BIOCARDIA INC Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield